Mphasis Q2 Results Live : Mphasis has declared their Q2 results on 16 October 2024, showcasing a strong financial performance with topline growth of 7.92% year-over-year (YoY) and a profit increase of 8.01% YoY.
Compared to the previous quarter, the revenue grew by 3.32%, while the profit saw a rise of 4.65%. This indicates a steady improvement in the company’s financial health.
The Selling, General & Administrative (SG&A) expenses have seen a decline of 0.98% quarter-over-quarter (q-o-q), although they increased by 2.77% YoY, reflecting ongoing operational efficiency efforts.
Mphasis reported an operating income increase of 5.99% q-o-q and a 7.43% YoY rise, highlighting robust operational management and revenue generation capabilities.
For Q2, the Earnings Per Share (EPS) stood at ₹22.18, marking a 7.57% increase YoY, which could be a positive indicator for shareholder returns.
In the past week, Mphasis has delivered a return of 0.42%, with a remarkable 26.14% return over the last six months and a 6.26% year-to-date return, showcasing strong market performance.
Currently, Mphasis holds a market capitalization of ₹55,073.63 crore, with a 52-week high of ₹3187.8 and a low of ₹2069.1, indicating significant valuation fluctuations over the year.
As of 17 October 2024, the consensus among 27 analysts covering Mphasis indicates a mixed outlook. While 2 analysts have rated the stock as a Strong Sell, 7 have given it a Sell rating, 7 have rated it as Hold, 7 as Buy, and 4 as Strong Buy.
The overall recommendation as of mid-October remains to Hold, suggesting that while Mphasis shows promising growth, analysts are cautious amidst market conditions.
